A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial.
Saved in:
| Title: | A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial. |
|---|---|
| Authors: | Alkema M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Smit MJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Marin-Mogollon C; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Totté K; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Teelen K; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., van Gemert GJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., van de Vegte-Bolmer M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Mordmüller BG; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Reimer JM; Novavax AB, Uppsala, Sweden., Lövgren-Bengtsson KL; Novavax AB, Uppsala, Sweden., Sauerwein RW; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands.; Present Address: TropIQ Health Sciences, Nijmegen, the Netherlands., Bousema T; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Plieskatt J; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark., Theisen M; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.; Centre for Medical Parasitology at Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Jore MM; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., McCall MBB; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands. matthew.mccall@radboudumc.nl. |
| Source: | BMC medicine [BMC Med] 2024 Apr 23; Vol. 22 (1), pp. 170. Date of Electronic Publication: 2024 Apr 23. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
